Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Depreciation and Depletion (2020 - 2025)

NeuroPace has reported Depreciation and Depletion over the past 6 years, most recently at $42000.0 for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $42000.0 for Q4 2025, down 12.5% from a year ago — trailing twelve months through Dec 2025 was $291000.0 (down 0.68% YoY), and the annual figure for FY2025 was $200000.0, down 3.38%.
  • Depreciation and Depletion for Q4 2025 was $42000.0 at NeuroPace, down from $100000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for NPCE hit a ceiling of $100000.0 in Q1 2021 and a floor of -$48000.0 in Q4 2023.
  • Median Depreciation and Depletion over the past 5 years was $100000.0 (2021), compared with a mean of $78350.0.
  • Biggest five-year swings in Depreciation and Depletion: crashed 155.17% in 2023 and later skyrocketed 200.0% in 2024.
  • NeuroPace's Depreciation and Depletion stood at $96000.0 in 2021, then decreased by 9.38% to $87000.0 in 2022, then crashed by 155.17% to -$48000.0 in 2023, then skyrocketed by 200.0% to $48000.0 in 2024, then fell by 12.5% to $42000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $42000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q2 2025) per Business Quant data.